Pilot Cohort Study of Rb-82 Myocardial PET Imaging to Evaluate Coronary Microvascular Dysfunction in Men With Prostate Cancer Receiving Androgen-Deprivation Therapy

Abramson Cancer Center at Penn Medicine

Status: Completed

Conditions: Prostate Cancer

Treatments: Device: myocardial PET imaging

Study type: Observational

Funder types: Other

Identifiers

NCT03535987

UPCC 18817

Details and patient eligibility

About

To determine the feasibility of using myocardial PET imaging as a means to assess cardiovascular risk in men with prostate cancer planned for androgen- deprivation therapy with external beam radiation therapy.

Enrollment: 18 patients

Sex: Male

Ages: 51+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Either clinically localized prostate cancer or biochemically-recurrent prostate cancer patients who are planned for at least 6 months ADT with a GnRH agonist and curative-intent radiation therapy per their oncologic providers.
• Over 50 years of age. Calculated 10-year Framingham General Cardiovascular Risk Score of ≥10% at the time of planned initiation of ADT.
• Patients must be able to read and understand English.
• Participants must sign the informed consent form.

Exclusion criteria

• Prior treatment with GnRH agonist therapy.
• History of active asthma or other reactive airway disease.
• Ischemic cardiac event (myocardial infarction, unstable angina) within the preceding 6 months.

Trial design

18 participants in 1 patient group

Observational

Description:

To determine the feasibility of using myocardial PET imaging

Treatment:

Device: myocardial PET imaging